# Linerixibat Compassionate Use for Cholestatic Pruritus Adult Patients With Primary Biliary Cholangitis (PBC)

> **NCT05448170** · — · AVAILABLE · sponsor: **GlaxoSmithKline**

## Conditions studied

- Pruritus

## Interventions

- **DRUG:** Linerixibat

## Key facts

- **NCT ID:** NCT05448170
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2025-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05448170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05448170, "Linerixibat Compassionate Use for Cholestatic Pruritus Adult Patients With Primary Biliary Cholangitis (PBC)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05448170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*